Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical …

Zhongguo Zhong yao za zhi= Zhongguo zhongyao …, 2013 - europepmc.org
To evaluate the effects and safety of varying doses of Guizhi Fuling capsule on treating
primary dysmenorrhea. From August 2010 to March 2011, 240 subjects (aged 18-30) with …

Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical …

Y Liu, W Xiao, Z Wang, B Zhao, Z Zhou… - China Journal of …, 2013 - wprim.whocc.org.cn
To evaluate the effects and safety of varying doses of Guizhi Fuling capsule on treating
primary dysmenorrhea. From August 2010 to March 2011, 240 subjects (aged 18-30) with …

Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical …

YJ LIU, W XIAO, ZZ WANG, BJ ZHAO… - China Journal of …, 2013 - pesquisa.bvsalud.org
To evaluate the effects and safety of varying doses of Guizhi Fuling capsule on treating
primary dysmenorrhea. From August 2010 to March 2011, 240 subjects (aged 18-30) with …

Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical …

YJ Liu, W Xiao, ZZ Wang, BJ Zhao, ZM Zhou, HZ Jiang… - 2013 - pubmed.ncbi.nlm.nih.gov
To evaluate the effects and safety of varying doses of Guizhi Fuling capsule on treating
primary dysmenorrhea. From August 2010 to March 2011, 240 subjects (aged 18-30) with …

Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical …

LIU Yu-Jie, X Wei, W Zhen-Zhong… - China Journal of …, 2013 - pesquisa.bvsalud.org
To evaluate the effects and safety of varying doses of Guizhi Fuling capsule on treating
primary dysmenorrhea. From August 2010 to March 2011, 240 subjects (aged 18-30) with …